187 related articles for article (PubMed ID: 25344985)
1. Ovarian cancer biomarkers: current state and future implications from high-throughput technologies.
Leung F; Diamandis EP; Kulasingam V
Adv Clin Chem; 2014; 66():25-77. PubMed ID: 25344985
[TBL] [Abstract][Full Text] [Related]
2. From bench to bedside: discovery of ovarian cancer biomarkers using high-throughput technologies in the past decade.
Leung F; Diamandis EP; Kulasingam V
Biomark Med; 2012 Oct; 6(5):613-25. PubMed ID: 23075239
[TBL] [Abstract][Full Text] [Related]
3. HE4 in ovarian cancer: from discovery to clinical application.
Montagnana M; Danese E; Giudici S; Franchi M; Guidi GC; Plebani M; Lippi G
Adv Clin Chem; 2011; 55():1-20. PubMed ID: 22126021
[TBL] [Abstract][Full Text] [Related]
4. Discovery and application of protein biomarkers for ovarian cancer.
Gagnon A; Ye B
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):9-13. PubMed ID: 18196999
[TBL] [Abstract][Full Text] [Related]
5. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.
Jurisicova A; Jurisica I; Kislinger T
Expert Rev Proteomics; 2008 Aug; 5(4):551-60. PubMed ID: 18761466
[TBL] [Abstract][Full Text] [Related]
6. Proteomics and biomarkers for ovarian cancer diagnosis.
Zhang B; Barekati Z; Kohler C; Radpour R; Asadollahi R; Holzgreve W; Zhong XY
Ann Clin Lab Sci; 2010; 40(3):218-25. PubMed ID: 20689132
[TBL] [Abstract][Full Text] [Related]
7. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
[TBL] [Abstract][Full Text] [Related]
8. An overview of biomarkers for the ovarian cancer diagnosis.
Zhang B; Cai FF; Zhong XY
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):119-23. PubMed ID: 21632171
[TBL] [Abstract][Full Text] [Related]
9. Searching for a system: the quest for ovarian cancer biomarkers.
Rodland KD; Maihle NJ
Cancer Biomark; 2010-2011; 8(4-5):223-30. PubMed ID: 22045355
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for screening, diagnosis, and monitoring of ovarian cancer.
Kobayashi E; Ueda Y; Matsuzaki S; Yokoyama T; Kimura T; Yoshino K; Fujita M; Kimura T; Enomoto T
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1902-12. PubMed ID: 22962405
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic markers for early detection of ovarian cancer.
Visintin I; Feng Z; Longton G; Ward DC; Alvero AB; Lai Y; Tenthorey J; Leiser A; Flores-Saaib R; Yu H; Azori M; Rutherford T; Schwartz PE; Mor G
Clin Cancer Res; 2008 Feb; 14(4):1065-72. PubMed ID: 18258665
[TBL] [Abstract][Full Text] [Related]
12. Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers.
Wang K; Huang C; Nice EC
Expert Rev Proteomics; 2014 Apr; 11(2):179-205. PubMed ID: 24611605
[TBL] [Abstract][Full Text] [Related]
13. Identification of ovarian cancer-associated proteins in symptomatic women: A novel method for semi-quantitative plasma proteomics.
Shield-Artin KL; Bailey MJ; Oliva K; Liovic AK; Barker G; Dellios NL; Reisman S; Ayhan M; Rice GE
Proteomics Clin Appl; 2012 Apr; 6(3-4):170-81. PubMed ID: 22532453
[TBL] [Abstract][Full Text] [Related]
14. Early diagnosis of ovarian carcinoma: is a solution in sight?
Lutz AM; Willmann JK; Drescher CW; Ray P; Cochran FV; Urban N; Gambhir SS
Radiology; 2011 May; 259(2):329-45. PubMed ID: 21502390
[TBL] [Abstract][Full Text] [Related]
15. Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer.
Jackson D; Craven RA; Hutson RC; Graze I; Lueth P; Tonge RP; Hartley JL; Nickson JA; Rayner SJ; Johnston C; Dieplinger B; Hubalek M; Wilkinson N; Perren TJ; Kehoe S; Hall GD; Daxenbichler G; Dieplinger H; Selby PJ; Banks RE
Clin Cancer Res; 2007 Dec; 13(24):7370-9. PubMed ID: 18094419
[TBL] [Abstract][Full Text] [Related]
16. Discovery and validation of ovarian cancer biomarkers utilizing high density antibody microarrays.
Ramirez AB; Lampe PD
Cancer Biomark; 2010-2011; 8(4-5):293-307. PubMed ID: 22045360
[TBL] [Abstract][Full Text] [Related]
17. Proteomics in prostate cancer biomarker discovery.
Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
[TBL] [Abstract][Full Text] [Related]
18. Biomarker discovery in ovarian cancer.
Tung CS; Wong KK; Mok SC
Womens Health (Lond); 2008 Jan; 4():27-40. PubMed ID: 19072449
[TBL] [Abstract][Full Text] [Related]
19. ACR appropriateness criteria© ovarian cancer screening.
Brown DL; Andreotti RF; Lee SI; Dejesus Allison SO; Bennett GL; Dubinsky T; Glanc P; Horrow MM; Lev-Toaff AS; Horowitz NS; Podrasky AE; Scoutt LM; Zelop CM
Ultrasound Q; 2010 Dec; 26(4):219-23. PubMed ID: 21084936
[TBL] [Abstract][Full Text] [Related]
20. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]